Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity ; volume:28 ; number:1 ; day:11 ; month:10 ; year:2023 ; pages:1-8 ; date:12.2023
European journal of medical research ; 28, Heft 1 (11.10.2023), 1-8, 12.2023
- Urheber
-
Thiruvengadam, Ramachandran
Rizvi, Zaigham Abbas
Raghavan, Sreevatsan
Murugesan, Deepika Rathna
Gosain, Mudita
Dandotiya, Jyotsna
Ayushi
Samal, Sweety
Pandey, Anil K.
Wadhwa, Nitya
Bhatnagar, Shinjini
Awasthi, Amit
Garg, Pramod Kumar
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-023-01373-3
- URN
-
urn:nbn:de:101:1-2024020113522413934800
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thiruvengadam, Ramachandran
- Rizvi, Zaigham Abbas
- Raghavan, Sreevatsan
- Murugesan, Deepika Rathna
- Gosain, Mudita
- Dandotiya, Jyotsna
- Ayushi
- Samal, Sweety
- Pandey, Anil K.
- Wadhwa, Nitya
- Bhatnagar, Shinjini
- Awasthi, Amit
- Garg, Pramod Kumar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Effects of the Omicron variant on perinatal outcomes in full-term neonates
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Possibility of COVID-19 eradication with evolution of a new omicron variant
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Effects of the Omicron variant on perinatal outcomes in full-term neonates
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Possibility of COVID-19 eradication with evolution of a new omicron variant
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Effects of the Omicron variant on perinatal outcomes in full-term neonates
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination